Liwanli Innovation Co., Ltd. (3054) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Liwanli Innovation Co., Ltd. (3054:TWSE), powered by AI.

Current Price
$67.80
Sector
Healthcare
What is the Liwanli Innovation Co., Ltd. stock price forecast?

Liwanli Innovation Co., Ltd. is currently trading at $67.80. View real-time AI analysis on Alpha Lenz.

What is Liwanli Innovation Co., Ltd. insider trading activity?

View the latest insider trading data for Liwanli Innovation Co., Ltd. on Alpha Lenz.

What is Liwanli Innovation Co., Ltd.'s P/E ratio?

View Liwanli Innovation Co., Ltd.'s valuation metrics on Alpha Lenz.

Liwanli Innovation Co., Ltd.

TWSE · 3054
NT$67.80+0.10(+0.15%)
Ask about Liwanli Innovation Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Liwanli Innovation Co., Ltd.'s ROE is 17.5%. Explore profitability and growth together.

Ask for details

Company Overview

Liwanli Innovation Co., Ltd. is a company engaged in the development and manufacturing of cooling solutions, often specializing in technologies servicing a wide array of electronics. Recognized for its innovative approach in creating high-performance cooling systems, the company addresses the needs of both consumer electronics and industrial applications. With a focus on efficient thermal management, Liwanli designs products like heat sinks, thermal pads, and cooling fans that contribute to the enhanced performance and longevity of electronic devices. These solutions are crucial in sectors such as computer hardware, telecommunications, and energy systems, where maintaining optimal temperatures is pivotal. The company holds a significant role in the market by driving technological advancements in cooling systems, thereby indirectly supporting the productivity and sustainability of other tech-driven industries. By continually improving thermal management techniques, Liwanli Innovation Co., Ltd. helps various sectors meet the increasing demand for efficient and reliable electronic components.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$125.54MRevenue
0.00Shares Out
0Employees

Margins

31.15%Gross
129.87%EBITDA
-57.11%Operating
126.06%Pre-Tax
125.97%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

54.58%Rev 3Yr
-14.63%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

16.36%ROA
17.48%ROE
16.44%ROIC

Financial Health

NT$146.37MCash & Cash Equivalents
NT$-60.83MNet Debt
8.10%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Liwanli Innovation Co., Ltd. (ticker: 3054) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).

The current price is 67.8 with a P/E ratio of -x and P/B of -x.

ROE is 17.48% and operating margin is -57.11%. Annual revenue is $126M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Liwanli Innovation Co., Ltd. (3054) Stock Forecast 2026 $67.80 — Price, Financials & Analyst Targets | Alpha Lenz